Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus

Title: Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus
Authors: Kuznetsova, Nadezhda; Siniavin, Andrei; Butenko, Alexander; Larichev, Victor; Kozlova, Alina; Usachev, Evgeny; Nikiforova, Maria; Usacheva, Olga; Shchetinin, Alexey; Pochtovyi, Andrei; Shidlovskaya, Elena; Odintsova, Alina; Belyaeva, Elizaveta; Voskoboinikov, Aleksander; Bessonova, Arina; Vasilchenko, Lyudmila; Karganova, Galina; Zlobin, Vladimir; Logunov, Denis; Gushchin, Vladimir; Gintsburg, Alexander
Contributors: Kemenesi, Gábor; Ministry of Health of the Russian Federation
Source: PLOS ONE ; volume 18, issue 5, page e0284823 ; ISSN 1932-6203
Publisher Information: Public Library of Science (PLoS)
Publication Year: 2023
Collection: PLOS Publications (via CrossRef)
Description: Tick-borne encephalitis virus (TBEV) is one of the most threatening pathogens which affects the human central nervous system (CNS). TBEV circulates widely in Northern Eurasia. According to ECDC, the number of TBE cases increase annually. There is no specific treatment for the TBEV infection, thus vaccination is the main preventive measure. Despite the existence of several inactivated vaccines currently being licensed, the development of new TBEV vaccines remains a leading priority in countries endemic to this pathogen. Here we report new recombinant virus made by infectious subgenomic amplicon (ISA) approach using TBEV and yellow fever virus vaccine strain (YF17DD-UN) as a genetic backbone. The recombinant virus is capable of effective replication in mammalian cells and induce TBEV-neutralizing antibodies in mice. Unlike the original vector based on the yellow fever vaccine strain, chimeric virus became neuroinvasive in doses of 10 7 −10 6 PFU and can be used as a model of flavivirus neuroinvasiveness, neurotropism and neurovirulence. These properties of hybrid structures are the main factors limiting their practical use as vaccines platforms.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1371/journal.pone.0284823
Availability: https://doi.org/10.1371/journal.pone.0284823; https://dx.plos.org/10.1371/journal.pone.0284823
Rights: http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.15EE0839
Database: BASE